EFFECT OF CHEWING GUM ON CONTROLLING NAUSEA/VOMITING AND THIRST IN PATIENTS WITH ACUTE PANCREATITIS

Sponsor
TC Erciyes University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06077188
Collaborator
(none)
60
2
3

Study Details

Study Description

Brief Summary

Nausea and vomiting are one of the most common symptoms in acute pancreatitis. In addition to pharmacological methods for nausea and vomiting, non-pharmacological methods can also be used. Among these, anticipatory nausea and vomiting can be prevented by behaviors aimed at distracting attention. This study will be conducted to evaluate the effect of chewing gum on the severity of nausea-vomiting and thirst in patients with acute pancreatitis. The study will be conducted with a total of 60 patients, 30 intervention and 30 control.

Patients in the intervention group will chew xylitol gum five times a day for three days. The patients' thirst and nausea and vomiting conditions will be examined.

Condition or Disease Intervention/Treatment Phase
  • Other: Gum group
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Erciyes University
Anticipated Study Start Date :
Nov 1, 2023
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Feb 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: intervention group

Other: Gum group
Group chewing gum with xylitol

No Intervention: Control group

Outcome Measures

Primary Outcome Measures

  1. Thirst Severity -Visual Analog Scale [Apply in the morning of the 1st day after application]

    Visual Analog Scale is a 10 cm long scale that evaluates the severity of thirst.

Secondary Outcome Measures

  1. Rhodes Nausea, Vomiting and Retching Index [Apply in the morning of the 1st day after application]

    It is an eight-item scale that measures the number and severity of patients' nausea, vomiting and retching in the last 24 hours.

  2. Rhodes Nausea, Vomiting and Retching Index ( [Apply in the morning of the 1st day after application]

    It is an eight-item scale that measures the number and severity of patients' nausea, vomiting and retching in the last 24 hours.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Those diagnosed with acute pancreatitis,

  • Without total dental prosthesis,

  • Without salivary gland infection,

  • Those who have not had salivary gland surgery,

  • No difficulty in chewing,

  • Not receiving oxygen therapy,

  • Able to answer all questions and be communicativ

Exclusion Criteria:
  • Those with diabetes,

  • Does not like chewing gum,

  • Receiving radiotherapy or chemotherapy,

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • TC Erciyes University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Özlem Ceyhan, Teaching staff, TC Erciyes University
ClinicalTrials.gov Identifier:
NCT06077188
Other Study ID Numbers:
  • Thirstgum
First Posted:
Oct 11, 2023
Last Update Posted:
Oct 13, 2023
Last Verified:
Oct 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Özlem Ceyhan, Teaching staff, TC Erciyes University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 13, 2023